Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

Blood (2020) 135 (16): 1386–1395.

https://doi.org/10.1182/blood.2019002887

Published: 2020

Includes: Supplemental data

Journal Articles

Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age

Koji Kawamura, Junya Kanda, MD, Sachiko Seo, MDPhD, Fumihiko Kimura, MD PhD, Masahiro Hirayama, MD PhD, Naoyuki Uchida, MD PhD, Noriko Doki, MD PhD, Takahiro Fukuda, Yukiyasu Ozawa, MD PhD, Yuta Katayama, MD PhD, Minoko Takanashi, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2019) 134 (Supplement_1): 46.

https://doi.org/10.1182/blood-2019-125032

Published: 2019

Journal Articles

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

Hiroyuki Muranushi, MD, Takero Shindo, MD PhD, Masakatsu Hishizawa, MD PhD, Masahito Tokunaga, MD PhD, Atsushi Wake, MD PhD, Nobuaki Nakano, MD, Tetsuya Eto, MD PhD, Michihiro Hidaka, MD PhD, Ilseung Choi, MD PhD, Toshihiro Miyamoto, MD PhD, Naoyuki Uchida, MD PhD, Yukiyoshi Moriuchi, MD, Yasuhiko Miyazaki, MD PhD, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, MD PhD, Koji Kato, MD PhD

Blood (2019) 134 (Supplement_1): 2008.

https://doi.org/10.1182/blood-2019-123318

Published: 2019

Journal Articles

Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival

Elizabeth Krieger, MD, Urmila Sivagnanaling, Katherine Webb, Dana Broadway, Catherine Roberts, PhD, John M. McCarty, MD, Christina M. Wiedl, DO, Rizwan Romee, MD PhD, Armand Keating, MD, Rehan Qayyum, Amir Ahmed Toor, MBBS

Blood (2019) 134 (Supplement_1): 4616.

https://doi.org/10.1182/blood-2019-129384

Published: 2019

Journal Articles

Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia (AML)

Blood (2019) 134 (Supplement_1): 4599.

https://doi.org/10.1182/blood-2019-131011

Published: 2019

Journal Articles

NMDP/CIBMTR donor selection guidelines

Blood (2019) 134 (12): 994.

https://doi.org/10.1182/blood.2019002898

Published: 2019

Journal Articles

The Role of Donor Selection for a Second Allogeneic Stem Cell Transplantation in Patients with AML Relapsing after a First Transplant; A Study on Behalf of the Acute Leukemia Working Party of EBMT

Avichai Shimoni, MD, Myriam Labopin, MD, Jürgen Finke, MD, Fabio Ciceri, MD, Eric Deconinck, MD PhD, Nicolaus Kröger, MD, Martin Gramatzki, MD, Matthias Stelljes, MD, Didier Blaise, Friedrich Stoelzel, Patrice Chevallier, MD, Ernst Holler, MD PhD, Nathalie Fegueux, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 3460.

https://doi.org/10.1182/blood-2018-99-110614

Published: 2018

Journal Articles

Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies

Rui MA, Xiao-Jun Huang, Lan-Ping Xu, Kaiyan Liu, Xiaohui Zhang, MD, Chen-Hua Yan, Wei Han, Feng-Rong Wang, Yu-Hong Chen, Huan Chen, Yao Chen, MD, Jing-Zhi Wang, Yu Wang

Blood (2018) 132 (Supplement 1): 3463.

https://doi.org/10.1182/blood-2018-99-113961

Published: 2018

Journal Articles

Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Blood (2018) 132 (Supplement 1): 2162.

https://doi.org/10.1182/blood-2018-99-111242

Published: 2018

Journal Articles

Comparison of Outcomes Following Allogeneic HCT for Adverse Cytogenetic/Molecular Risk AML Using T-Replete Haploidentical Donors to Optimally Matched Related and Unrelated Donors

Asad Bashey, MD PhD, Xu Zhang, PhD, Stacey Brown, CCRP, Katelin C Jackson, Lawrence E Morris, MD, H. Kent Holland, MD, Melhem M Solh, MD, Scott R Solomon, MD

Blood (2017) 130 (Supplement 1): 4608.

https://doi.org/10.1182/blood.V130.Suppl_1.4608.4608

Published: 2017

Journal Articles

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Blood (2017) 130 (Supplement 1): 848.

https://doi.org/10.1182/blood.V130.Suppl_1.848.848

Published: 2017

Journal Articles

Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm

Eduardo Rodríguez-Arbolí, MD, Francisco J. Márquez-Malaver, RN, Nancy Rodríguez-Torres, MD, Teresa Caballero-Velázquez, MD PhD, Virginia Escamilla Gomez, Cristina Calderón-Cabrera, MD, José F. Falantes, MD, Ildefonso Espigado, MD PhD, José A. Pérez-Simón

Blood (2017) 130 (Supplement 1): 5548.

https://doi.org/10.1182/blood.V130.Suppl_1.5548.5548

Published: 2017

Journal Articles

Selection of Unrelated Allogeneic Hematopoietic Cell Donors Based on KIR3DL1 Allotypes Is Feasible and Results in Improved Disease-Free Survival in Transplant Recipients with MDS and AML

Brian C. Shaffer, MD, Glenn Heller, PhD, Jean-Benoit Le Luduec, PhD, Jack Vahradian, Miguel Perales, MD, Sergio A. Giralt, MD, Roni Tamari, MD, Boglarka Gyurkocza, MD, Ann A. Jakubowski, MD PhD, E B Papadopoulos, MD, Jeanette E Boudreau, BSc, PhD, Nancy A. Kernan, MD, Katharine C. Hsu, MD PhD

Blood (2016) 128 (22): 990.

https://doi.org/10.1182/blood.V128.22.990.990

Published: 2016

Journal Articles

Treatment Use Study of Platelet Components Treated with Amotosalen and Ultraviolet a Light in Response to Emerging Arboviruses in Puerto Rico - True Study Final Results

Salvador Rico, Susan L. Stramer, PhD, Richard J. Benjamin, MD PhD, Edgardo Cartagena, Axel Arroyo, Nelson Robles, Simon Carlo, L Vera, P Solivan-Ortiz, Norman Huang, Claudia Koontz, Travis Berry, Laurence Corash

Blood (2016) 128 (22): 3844.

https://doi.org/10.1182/blood.V128.22.3844.3844

Published: 2016

Journal Articles

Evolving Criteria for Donor Selection for Transplants in Acute Myeloid Leukemia

Yu Wang, qi-Fa Liu, de-Pei Wu, Xiao-jun Huang

Blood (2016) 128 (22): 5846.

https://doi.org/10.1182/blood.V128.22.5846.5846

Published: 2016

Journal Articles

Who Is the Better Donor for Young Hematopoietic Transplant Recipients without Siblings: An Older-Aged Haploidentical Parental Donor or a Young Unrelated Donor?

Mingming Zhang, Yi Luo, Yamin Tan, Jimin Shi, Weiyan Zheng, Yanmin Zhao, Zhen Cai, MD PhD, He Huang, MD PhD

Blood (2016) 128 (22): 2290.

https://doi.org/10.1182/blood.V128.22.2290.2290

Published: 2016

Journal Articles

A Comparative Study of Solubility Based Sickle Cell Screening Versus Genomic Method in Blood Donors

Lohith shakaladevanapura Bachegowda, MD, Yelena Ginzburg, MD, Sunitha Vege, Connie Westhoff

Blood (2015) 126 (23): 1148.

https://doi.org/10.1182/blood.V126.23.1148.1148

Published: 2015

Journal Articles

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Blood (2015) 126 (23): 2004.

https://doi.org/10.1182/blood.V126.23.2004.2004

Published: 2015

Journal Articles

Related Nonmyeloablative Haploidentical (mini-haplo) Blood or Marrow Transplantation (BMT) with High-Dose Post-Transplant Cyclophosphmade (PTCy) for Acute Myeloid Leukemia (AML): Donor Age Impacts Outcome

Margaret M. Showel, MD, Ephraim J. Fuchs, Ravi Varadhan, PhD, Mark J. Levis, MD PhD, Richard J. Jones, Sr., MD

Blood (2015) 126 (23): 151.

https://doi.org/10.1182/blood.V126.23.151.151

Published: 2015

Journal Articles

High Rates of Passive CMV Antibody Acquisition Pre-Allograft in Patients Receiving Plasma-Rich CMV Unselected and Leukodepleted Blood Components: A Caution for Donor Selection

Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Unell Riley, Mark Ethell, MD, Michael N Potter, MD PhD

Blood (2014) 124 (21): 1140.

https://doi.org/10.1182/blood.V124.21.1140.1140

Published: 2014

NARROW

External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival

Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia (AML)

NMDP/CIBMTR donor selection guidelines

The Role of Donor Selection for a Second Allogeneic Stem Cell Transplantation in Patients with AML Relapsing after a First Transplant; A Study on Behalf of the Acute Leukemia Working Party of EBMT

Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies

Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Comparison of Outcomes Following Allogeneic HCT for Adverse Cytogenetic/Molecular Risk AML Using T-Replete Haploidentical Donors to Optimally Matched Related and Unrelated Donors

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm

Selection of Unrelated Allogeneic Hematopoietic Cell Donors Based on KIR3DL1 Allotypes Is Feasible and Results in Improved Disease-Free Survival in Transplant Recipients with MDS and AML

Treatment Use Study of Platelet Components Treated with Amotosalen and Ultraviolet a Light in Response to Emerging Arboviruses in Puerto Rico - True Study Final Results

Evolving Criteria for Donor Selection for Transplants in Acute Myeloid Leukemia

Who Is the Better Donor for Young Hematopoietic Transplant Recipients without Siblings: An Older-Aged Haploidentical Parental Donor or a Young Unrelated Donor?

A Comparative Study of Solubility Based Sickle Cell Screening Versus Genomic Method in Blood Donors

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Related Nonmyeloablative Haploidentical (mini-haplo) Blood or Marrow Transplantation (BMT) with High-Dose Post-Transplant Cyclophosphmade (PTCy) for Acute Myeloid Leukemia (AML): Donor Age Impacts Outcome

High Rates of Passive CMV Antibody Acquisition Pre-Allograft in Patients Receiving Plasma-Rich CMV Unselected and Leukodepleted Blood Components: A Caution for Donor Selection

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only